Oncotarget

Research Papers:

AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression

Xuejiao Shi, Zhaoli Chen, Xueda Hu, Mei Luo, Zengmiao Sun, Jiagen Li, Susheng Shi, Xiaoli Feng, Chengcheng Zhou, Zitong Li, Wenhui Yang, Yuan Li, Pan Wang, Fang Zhou, Yibo Gao and Jie He _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:36407-36418. https://doi.org/10.18632/oncotarget.9239

Metrics: PDF 2769 views  |   HTML 2472 views  |   ?  


Abstract

Xuejiao Shi1, Zhaoli Chen1, Xueda Hu1, Mei Luo1, Zengmiao Sun1, Jiagen Li1, Susheng Shi2, Xiaoli Feng2, Chengcheng Zhou1, Zitong Li1, Wenhui Yang1, Yuan Li1, Pan Wang1, Fang Zhou1, Yibo Gao1, Jie He1

1Department of Thoracic Surgery, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

2Department of Pathology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

Correspondence to:

Yibo Gao, email: [email protected]

Jie He, email: [email protected]

Keywords: AJUBA, ERK1/2, MMP10, MMP13, ESCC

Received: December 16, 2015     Accepted: April 22, 2016     Published: May 09, 2016

ABSTRACT

The LIM-domain protein AJUBA has been reported to be involved in cell-cell adhesion, proliferation, migration and cell fate decision by acting as a scaffold or adaptor protein. We previously identified AJUBA as a putative cancer gene in esophageal squamous cell carcinoma (ESCC). However, the function and underlying mechanisms of AJUBA in ESCC remain largely unknown. In the present study, we detected AJUBA levels in ESCC tumor tissues and in corresponding adjacent non-tumor tissues by immunohistochemistry (IHC) and investigated the function and mechanism of AJUBA in ESCC cells. The IHC results showed that AJUBA levels were significantly higher in ESCC tissues compared with corresponding adjacent non-tumor tissues (P < 0.001). Both in vitro and in vivo experiments showed that AJUBA promoted cell growth and colony formation, inhibited cisplatin-induced apoptosis of ESCC cells, and promoted ESCC cell migration and invasion. RNA sequencing was used to reveal the oncogenic pathways of AJUBA that were involved, and MMP10 and MMP13 were identified as two of the downstream targets of AJUBA. Thus, AJUBA upregulates the levels of MMP10 and MMP13 by activating ERK1/2. Taken together, these findings revealed that AJUBA serves as oncogenic gene in ESCC and may serve as a new target for ESCC therapy.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9239